PVCRoBIK: Robust Intelligent Keyboard for Quadraplegic Patients

Sponsor
Centre d'Investigation Clinique et Technologique 805 (Other)
Overall Status
Unknown status
CT.gov ID
NCT01707498
Collaborator
University of Versailles (Other)
20
1
2
59
0.3

Study Details

Study Description

Brief Summary

This is multi-center prospective randomized trial evaluating the effectiveness of a new brain-computer interface for communication of quadriplegic patients in a clinical context. This performance of this will compared to traditional assistive technology (scanning system) and to performance of a healthy volunteer population.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Scanning device
  • Procedure: RoBIK Brain-Computer Interface
N/A

Detailed Description

The evaluation aims to estimate the performance of BCIs in patient and healthy subjects in a clinical setting (primary objective) and to compare this performance with an existing assitive technology adapted to the target population of this study (scanning system). A quadriplegic patient population (n = 10) evaluated the two techniques and a population of healthy subjects (n = 10) evaluated the BCI only.

When a subject meets all the eligibility criteria and is not discarded by any non-inclusion criteria, he is included in the study. The order of the two techniques to be compared is randomized.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Clinical Evaluation of Brain-Computer Interface for Helping Communication of Quadriplegic Patients
Actual Study Start Date :
Feb 1, 2013
Anticipated Primary Completion Date :
Jan 1, 2018
Anticipated Study Completion Date :
Jan 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tetraplegic patients

Scanning device RoBIK Brain-Computer Interface

Procedure: Scanning device
Patients will be asked to spell a text with a specific scanning device. The most appropriate contactor or clicking device will be chosen by a senior therapist.

Procedure: RoBIK Brain-Computer Interface
Patients will be asked to spell a text with the BCI

Experimental: Healthy volunteers

RoBIK Brain-Computer Interface

Procedure: RoBIK Brain-Computer Interface
Patients will be asked to spell a text with the BCI

Outcome Measures

Primary Outcome Measures

  1. BIT RATE IN BIT PER MINUTE(bpm) [15 MINUTES]

    Bitrate (bpm): transfer of information from patient to computer in bits per minutes. This is a reference measurement to compare P300 speller Brain Computer Interfaces. It uses: number of choices on the interface (N), the average time to select one key (t) and the error rate (e)

Secondary Outcome Measures

  1. Installation time (seconds) [60 mns]

    Installation time (seconds), Number of caracters spelt in a pre-defined time, Error rate: Area Under the Receiver Operating Curve (AUROC), Balanced Error Rate (BER), Visual Analogous Scale for tiredness (before, after the use) and overall satisfaction.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Healthy volunteers:
  • Informed consent

  • Adults aged more than 18yo

  • Passed complete medical check-up (heart-rate, blood pressure,...)

  • Negative pregnancy test

Quadripleagic patients:
  • Informed consent

  • Adults aged more than 18years

  • Passed medical exam

  • Negative pregnancy test

  • Full medical checkup

  • haemodynamic stability

Exclusion Criteria:
Healthy volunteers:
  • history of epilepsy or seizure

  • auditory or visual deficit

  • atopic scalp dermatitis

  • hypersensitivity to gold

  • curator/guardianship/under protection of judicial authority

  • unable to understand the information note and/or to cooperate

  • no social security

  • can't read

Quadripleagic patients:
  • history of epilepsy or seizure

  • auditory or visual deficit

  • cerebral lesion

  • atopic scalp dermatitis

  • hypersensitivity to gold

  • curator/guardianship/under protection of judicial authority

  • unable to understand the information note and/or to cooperate

  • no social security

  • can't read

  • included in a different clinical trial with exclusion period

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital Raymond Poincare Garches France 92380

Sponsors and Collaborators

  • Centre d'Investigation Clinique et Technologique 805
  • University of Versailles

Investigators

  • Study Director: LOUIS MAYAUD, ENGINEER, CIC IT 805

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
david orlikowski, PROFESSOR, Centre d'Investigation Clinique et Technologique 805
ClinicalTrials.gov Identifier:
NCT01707498
Other Study ID Numbers:
  • 2012-A00613-40
First Posted:
Oct 16, 2012
Last Update Posted:
Feb 1, 2018
Last Verified:
Jan 1, 2018
Keywords provided by david orlikowski, PROFESSOR, Centre d'Investigation Clinique et Technologique 805
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2018